annual current liabilities:
$90.68M+$36.96M(+68.80%)Summary
- As of today (June 23, 2025), TGTX annual total current liabilities is $90.68 million, with the most recent change of +$36.96 million (+68.80%) on December 31, 2024.
- During the last 3 years, TGTX annual current liabilities has risen by +$25.30 million (+38.69%).
- TGTX annual current liabilities is now at all-time high.
Performance
TGTX Current liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly current liabilities:
$160.21M+$69.53M(+76.68%)Summary
- As of today (June 23, 2025), TGTX quarterly total current liabilities is $160.21 million, with the most recent change of +$69.53 million (+76.68%) on March 1, 2025.
- Over the past year, TGTX quarterly current liabilities has increased by +$60.52 million (+60.72%).
- TGTX quarterly current liabilities is now at all-time high.
Performance
TGTX quarterly current liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Current liabilities Formula
Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities
TGTX Current liabilities Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +68.8% | +60.7% |
3 y3 years | +38.7% | +193.1% |
5 y5 years | +7.4% | +153.8% |
TGTX Current liabilities Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | at high | +70.5% | at high | +339.6% |
5 y | 5-year | at high | +70.5% | at high | +339.6% |
alltime | all time | at high | >+9999.0% | at high | >+9999.0% |
TGTX Current liabilities History
Date | Annual | Quarterly |
---|---|---|
Mar 2025 | - | $160.21M(+76.7%) |
Dec 2024 | $90.68M(+68.8%) | $90.68M(-27.5%) |
Sep 2024 | - | $125.11M(+15.1%) |
Jun 2024 | - | $108.66M(+9.0%) |
Mar 2024 | - | $99.68M(+85.6%) |
Dec 2023 | $53.72M(+1.0%) | $53.72M(-6.9%) |
Sep 2023 | - | $57.68M(-20.6%) |
Jun 2023 | - | $72.67M(+15.2%) |
Mar 2023 | - | $63.08M(+18.6%) |
Dec 2022 | $53.20M(-18.6%) | $53.20M(+46.0%) |
Sep 2022 | - | $36.45M(-15.9%) |
Jun 2022 | - | $43.33M(-20.7%) |
Mar 2022 | - | $54.66M(-16.4%) |
Dec 2021 | $65.38M(-25.3%) | $65.38M(-25.4%) |
Sep 2021 | - | $87.66M(+0.1%) |
Jun 2021 | - | $87.55M(-5.3%) |
Mar 2021 | - | $92.49M(+5.6%) |
Dec 2020 | $87.55M(+3.7%) | $87.55M(+12.7%) |
Sep 2020 | - | $77.67M(+15.0%) |
Jun 2020 | - | $67.54M(+7.0%) |
Mar 2020 | - | $63.12M(-25.3%) |
Dec 2019 | $84.45M(+117.3%) | $84.45M(+5.3%) |
Sep 2019 | - | $80.20M(+43.3%) |
Jun 2019 | - | $55.97M(-8.2%) |
Mar 2019 | - | $60.94M(+56.8%) |
Dec 2018 | $38.85M(+39.0%) | $38.85M(-3.4%) |
Sep 2018 | - | $40.24M(+8.9%) |
Jun 2018 | - | $36.94M(+10.8%) |
Mar 2018 | - | $33.34M(+19.3%) |
Dec 2017 | $27.96M(+65.6%) | $27.96M(+41.3%) |
Sep 2017 | - | $19.79M(-4.7%) |
Jun 2017 | - | $20.76M(+5.2%) |
Mar 2017 | - | $19.73M(+16.9%) |
Dec 2016 | $16.88M(+60.3%) | $16.88M(-0.0%) |
Sep 2016 | - | $16.88M(+19.6%) |
Jun 2016 | - | $14.12M(+58.8%) |
Mar 2016 | - | $8.89M(-15.5%) |
Dec 2015 | $10.53M(+105.6%) | $10.53M(+8.7%) |
Sep 2015 | - | $9.69M(+5.2%) |
Jun 2015 | - | $9.21M(-3.6%) |
Mar 2015 | - | $9.55M(+86.5%) |
Dec 2014 | $5.12M(-18.9%) | $5.12M(-42.5%) |
Sep 2014 | - | $8.90M(+241.5%) |
Jun 2014 | - | $2.61M(+31.1%) |
Mar 2014 | - | $1.99M(-68.5%) |
Dec 2013 | $6.32M(+185.1%) | $6.32M(+11.3%) |
Sep 2013 | - | $5.68M(+63.8%) |
Jun 2013 | - | $3.47M(+40.2%) |
Mar 2013 | - | $2.47M(+11.6%) |
Dec 2012 | $2.22M(+38.0%) | $2.22M(-25.1%) |
Sep 2012 | - | $2.96M(+25.9%) |
Jun 2012 | - | $2.35M(+92.2%) |
Mar 2012 | - | $1.22M(-23.9%) |
Dec 2011 | $1.61M(-51.2%) | $1.61M(+6.0%) |
Sep 2011 | - | $1.52M(-59.9%) |
Jun 2011 | - | $3.78M(+12.9%) |
Mar 2011 | - | $3.35M(+1.8%) |
Dec 2010 | $3.29M | $3.29M(-21.7%) |
Date | Annual | Quarterly |
---|---|---|
Sep 2010 | - | $4.21M(-14.6%) |
Jun 2010 | - | $4.93M(-31.6%) |
Mar 2010 | - | $7.20M(+184.5%) |
Dec 2009 | $2.53M(+70.4%) | $2.53M(+58.4%) |
Sep 2009 | - | $1.60M(-11.1%) |
Jun 2009 | - | $1.80M(+81.0%) |
Mar 2009 | - | $993.10K(-33.2%) |
Dec 2008 | $1.49M(-20.6%) | $1.49M(-26.2%) |
Sep 2008 | - | $2.01M(+37.3%) |
Jun 2008 | - | $1.47M(-17.9%) |
Mar 2008 | - | $1.79M(-4.6%) |
Dec 2007 | $1.87M(-3.7%) | $1.87M(+4.5%) |
Sep 2007 | - | $1.79M(-29.2%) |
Jun 2007 | - | $2.53M(+15.4%) |
Mar 2007 | - | $2.19M(+12.8%) |
Dec 2006 | $1.94M(+16.7%) | $1.94M(+37.4%) |
Sep 2006 | - | $1.41M(-36.1%) |
Jun 2006 | - | $2.21M(-1.4%) |
Mar 2006 | - | $2.25M(+34.9%) |
Dec 2005 | $1.67M(+39.3%) | $1.67M(-7.9%) |
Sep 2005 | - | $1.81M(+24.7%) |
Jun 2005 | - | $1.45M(+14.2%) |
Mar 2005 | - | $1.27M(+6.3%) |
Dec 2004 | $1.20M(+23.8%) | $1.20M(-18.9%) |
Sep 2004 | - | $1.47M(+136.2%) |
Jun 2004 | - | $624.40K(-17.6%) |
Mar 2004 | - | $757.80K(-21.6%) |
Dec 2003 | $966.00K(-10.8%) | $966.00K(-23.7%) |
Sep 2003 | - | $1.27M(+20.0%) |
Jun 2003 | - | $1.05M(-0.8%) |
Mar 2003 | - | $1.06M(-1.8%) |
Dec 2002 | $1.08M(+113.0%) | $1.08M(+115.0%) |
Sep 2002 | - | $503.90K(+17.8%) |
Jun 2002 | - | $427.70K(-11.8%) |
Mar 2002 | - | $484.70K(-4.7%) |
Dec 2001 | $508.60K(-75.6%) | $508.60K(-32.0%) |
Sep 2001 | - | $748.40K(+5.9%) |
Jun 2001 | - | $706.90K(-9.3%) |
Mar 2001 | - | $779.20K(-62.5%) |
Dec 2000 | $2.08M(+316.1%) | $2.08M(+95.9%) |
Sep 2000 | - | $1.06M(+95.7%) |
Jun 2000 | - | $542.50K(+9.4%) |
Mar 2000 | - | $495.90K(-0.8%) |
Dec 1999 | $500.00K(-28.6%) | $500.00K(+150.0%) |
Sep 1999 | - | $200.00K(-50.0%) |
Jun 1999 | - | $400.00K(-33.3%) |
Mar 1999 | - | $600.00K(-14.3%) |
Dec 1998 | $700.00K(+75.0%) | $700.00K(+16.7%) |
Sep 1998 | - | $600.00K(0.0%) |
Jun 1998 | - | $600.00K(+200.0%) |
Mar 1998 | - | $200.00K(-50.0%) |
Dec 1997 | $400.00K(+33.3%) | $400.00K(+33.3%) |
Sep 1997 | - | $300.00K(-25.0%) |
Jun 1997 | - | $400.00K(+33.3%) |
Mar 1997 | - | $300.00K(0.0%) |
Dec 1996 | $300.00K | $300.00K(0.0%) |
Sep 1996 | - | $300.00K(-25.0%) |
Jun 1996 | - | $400.00K |
FAQ
- What is TG Therapeutics annual total current liabilities?
- What is the all time high annual current liabilities for TG Therapeutics?
- What is TG Therapeutics annual current liabilities year-on-year change?
- What is TG Therapeutics quarterly total current liabilities?
- What is the all time high quarterly current liabilities for TG Therapeutics?
- What is TG Therapeutics quarterly current liabilities year-on-year change?
What is TG Therapeutics annual total current liabilities?
The current annual current liabilities of TGTX is $90.68M
What is the all time high annual current liabilities for TG Therapeutics?
TG Therapeutics all-time high annual total current liabilities is $90.68M
What is TG Therapeutics annual current liabilities year-on-year change?
Over the past year, TGTX annual total current liabilities has changed by +$36.96M (+68.80%)
What is TG Therapeutics quarterly total current liabilities?
The current quarterly current liabilities of TGTX is $160.21M
What is the all time high quarterly current liabilities for TG Therapeutics?
TG Therapeutics all-time high quarterly total current liabilities is $160.21M
What is TG Therapeutics quarterly current liabilities year-on-year change?
Over the past year, TGTX quarterly total current liabilities has changed by +$60.52M (+60.72%)